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Abstract
Purpose Three-dimensional surface imaging (3D-SI) of the breasts enables the measurement of breast volume and shape 
symmetry. If these measurements were sufficiently accurate and repeatable, they could be used in planning oncological breast 
surgery and as an objective measure of aesthetic outcome. The aim of this study was to validate the measurements of breast 
volume and symmetry provided by the Vectra XT imaging system.
Methods To validate measurements, breast phantom models of true volume between 100 and 1000 cm3 were constructed and 
varying amounts removed to mimic breast tissue ‘resections’. The volumes of the phantoms were measured using 3D-SI by 
two observers and compared to a gold standard. For intra-observer repeatability and inter-observer reproducibility in vivo, 
16 patients who had undergone oncological breast surgery had breast volume and symmetry measured three times by two 
observers.
Results A mean relative difference of 2.17 and 2.28% for observer 1 and 2 respectively was seen in the phantom measure-
ments compared to the gold standard (n = 45, Bland Altman agreement). Intra-observer variation over ten repeated meas-
urements demonstrated mean coefficients of variation (CV) of 0.58 and 0.49%, respectively. The inter-observer variation 
demonstrated a mean relative difference of 0.11% between the two observers. In patients, intra-observer variation over three 
repeated volume measurements for each observer was 3.9 and 3.8% (mean CV); the mean relative difference between observ-
ers was 5.78%. For three repeated shape symmetry measurements using RMS projection difference between the two breasts, 
the intra-observer variations were 8 and 14% (mean CV), the mean relative difference between observers was 0.43 mm for 
average symmetry values that ranged from about 3.5 to 15.5 mm.
Conclusion This first validation of breast volume and shape symmetry measurements using the Vectra XT 3D-SI system 
suggests that these measurements have the potential to assist in pre-operative planning and also as a measure of aesthetic 
outcome.
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Introduction
Three-dimensional surface imaging (3D-SI), first 
described by Burke and Beard [1, 2] in 1967 to analyse 
facial structures, is now also used in the aesthetic breast 
surgery setting, mainly as a marketing tool. Patients can 
visualize three-dimensional (3D) images of themselves 
and their plastic surgeon can manipulate these images to 
simulate the expected appearances after breast augmen-
tation or reduction. Clinicians and researchers can also 
exploit 3D-SI to measure breast volume and symmetry 
in pre-operative planning, to investigate volume reten-
tion after lipofilling and use it as a measure of cosmetic 
outcome after surgery [3]. Moreover, the ability to meas-
ure the shape symmetry, which reports not only on the 
volume but also on the surface shape, is advantageous 
[4]. By reflecting the mirror image of one of the patient’s 
breasts onto the other, the distance between the two breast 
surfaces may be calculated over the entire surface of the 
breast from the superimposed images. However, 3D-SI has 
not hitherto been exploited in a breast cancer population. 
In these patients, where body mass index is higher [5] 
compared to the slim build of the aesthetic breast augmen-
tation population [6], 3D-SI may not give accurate vol-
ume measurements as it requires an assumption about the 
depth and curvature of the underlying chest wall. Thus, the 
validity of the volume and symmetry measurements in this 
population remains unknown and its use as a clinical tool 
is not established. The aim of this study, therefore, was 
to validate breast volume measurement using the Vectra 
XT (Canfield Sci, New Jersey, USA), a popular 3D imag-
ing system used worldwide, and to investigate the repro-
ducibility of measuring breast volume and symmetry in a 
breast cancer population who had undergone oncological 
breast surgery.
Methods
Phantom model evaluation
The breast phantoms were made of plasticine (NCP 
Newclay Products, Devon, UK). Six phantoms were con-
structed, each of a different volume (Fig. 1), incorporating 
a wide range of breast volumes. ‘Resections’ were sequen-
tially excised from each phantom and after each resection 
the phantom was re-imaged. The resections were used to 
represent typical excision biopsies, wide local excisions 
and therapeutic mammoplasties. In total, 45 phantoms 
were imaged with the following starting volumes (num-
ber of resections in parentheses): 100 (5), 200 (5), 300 
(5), 400 (5), 500 (9) and 1000 (10)  cm3. The gold standard 
volume of each phantom was measured initially and after 
every resection using the Archimedes’ principle of water 
displacement. The phantoms were placed on a wooden 
board held 1.5 metres from, and parallel to, the Vectra 
XT. 3D-SI of the phantoms initially and after every resec-
tion was carried out using a standard protocol available 
in the Vectra Analysis Module (VAM) software (Canfield 
Sci, New Jersey, USA). By identifying a region of inter-
est (ROI) including an area bounded by a 2-cm perimeter 
drawn on the 3D image beyond the boundary of the phan-
tom, the posterior wall of the phantom was interpolated 
from the ROI data and the volume enclosed by the breast 
phantom and its estimated posterior wall was calculated. 
Two observers independently measured the volume for 
each phantom 10 times, from which the mean volume and 
coefficient of variation (CV) were calculated.
The volume measurement accuracy was obtained by 
comparing the mean volumes for each phantom measured 
by 3D-SI to the gold standard. Agreement between the two 
methods was determined using Bland Altman plots [7] dis-
playing the relative difference between the mean of the ten 
estimates and the gold standard volume ((mean 3D-SI vol-
ume − gold standard volume)/gold standard × 100) as a 
function of the gold standard volume, and ‘limits of agree-
ment’ (overall mean relative difference +/− 1.96SD of the 
mean relative difference).
To assess intra-observer variation, the coefficient of vari-
ation (CV = SD/mean) for the 10 measurements of each of 
phantom was calculated and then the mean of the CV was 
calculated as an indication of the variation in repeated meas-
urements for all of the phantoms.
Inter-observer agreement was measured using a Bland 
Altman plot showing the relative difference between the 
means of ten estimates for each observer ((mean volume 
Fig. 1  Image of breast phantom made of plasticine taken using the 
Vectra XT camera. The observer has identified a region of inter-
est around the perimeter of the phantom that includes an area 2 cm 
beyond the boundary of the model
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observer 1 − mean volume observer 2)/(mean of mean 
volumes for observer 1 and 2) × 100) as a function of the 
mean of the two observers’ mean volume measurements, 
and ‘limits of agreement’ (overall mean relative difference 
+/− 1.96 SD of the mean relative difference).
In vivo patient evaluations
Following Regional Ethics Committee approval (REC num-
ber 14/YH/0175) 16 patients were recruited to the study. 
Informed consent was obtained from all individual partici-
pants included in the study. Additional informed consent was 
obtained from the participant whose images are included in 
this article. Participants were positioned 1.5 m away from 
the Vectra XT. The participant’s face was excluded from all 
images. Participants were imaged with their hands on their 
hips at the end of normal inspiration.
Measurement of volume
After attempting to measure volume using simple place-
ment of landmarks and the in-built software, and secondly 
by simply marking an ROI by eye, we concluded that there 
was too much variation and this had an unacceptable impact 
on reproducibility. Therefore to calculate the breast volume 
using the VAM software (Canfield Sci, New Jersey, USA), a 
specific protocol was developed (Fig. 2). A grid was placed 
on the image of the breast in the x, y, z planes, with each grid 
cube having a side of 2 cm. The y axis was positioned at the 
midline, with the upper border of the grid at the suprasternal 
notch. A region of interest (ROI) was identified around the 
perimeter of the breast as follows:
1. Vertically down the midline from one square below the 
suprasternal notch to one square below the most medial 
aspect of the infra-mammary fold (IMF).
2. Then moving laterally at a level one square below the 
IMF to the anterior axillary line following parallel to the 
curve of the IMF or ptosis of breast (whichever is more 
caudal).
3. Then moving superiorly along the anterior axillary line 
towards the axilla.
4. Then moving medially to define the superior border to 
meet the midline one square below the clavicle.
The volume measurements were undertaken by two 
observers imaging each patient three times. The left and 
right breasts were treated independently.
To assess intra-observer variation, the mean CV for all 
breasts was calculated. Bland Altman plots were used to 
measure inter-observer variation and agreement as described 
for the phantom studies.
Measurement of shape symmetry
Similarly, a protocol was developed to measure symmetry. 
For each 3D image:
1. The torso was rotated to anterior-posterior view (AP) 
view (Fig. 3a).
2. The gridlines were place onto the image so that the y 
axis (x = 0) bisected the torso. The image was cropped 
so that only the breast area was visible. (Fig. 3b).
3. The torso was viewed cranio-caudally and the shoul-
ders/clavicles aligned along the line of z = 0 in case the 
patient was not standing parallel to the Vectra XT cam-
eras at the time of imaging (Fig. 3c).
4. The image was rotated 90° laterally and cropped either 
side at the level of the anterior axillary line (Fig. 3d, e).
5. The image was returned to the AP position. One-half of 
the torso was selected from the y axis laterally using a 
lasso tool provided within the VAM software (Fig. 3f).
6. The whole image was copied and reflected with the y 
axis as the line of symmetry, inverting the z-axis data 
so that in both the original and the reflected images the 
z position of the breast surface was positive. Using the 
VAM software, the distances along the z axis (skin sur-
face ‘height’) between the corresponding x–y coordi-
nate points on the original image and the reflected image 
were measured. (Fig. 3g). This measurement was termed 
the height difference (HD). The degree of asymmetry 
was then quantified using the RMS projection differ-
ence (RMS-PD), as the square root of the mean of the 
squared HDs, which gives a positive value regardless of 
whether left is larger than right or vice versa. The lower 
the number, the more symmetrical the breasts is.Fig. 2  Method developed to measure volume using Vectra-XT 3D-SI
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Both observers calculated the RMS-PD for each of the 
three images of each patient. To assess intra-observer vari-
ation, the mean of the CV was calculated. A Bland Altman 
plot was used to measure inter-observer agreement and vari-
ation as above.
Data were entered into an excel spread sheet (Microsoft 
Corp., Redmond, Washington) and analysed using SPSS sta-
tistical software (SPSS v22; SPSS, Inc., Chicago).
Results
Phantom model evaluations
Accuracy
The mean relative differences for observers 1 and 2 com-
pared with the gold standard were 2.17 and 2.28% with lim-
its of agreement of − 0.42 to 4.76% and − 0.33 to 4.95%, 
respectively (Fig. 4a, b).
Intra-observer variability
The mean CVs were 0.58 and 0.49% for observers 1 and 2, 
respectively. No significant correlation was seen between 
CV and volume (correlation coefficients 0.026 and 0.273, 
and p values 0.867 and 0.069, respectively, for observer 1 
and 2), thus justifying the averaging of CV over phantoms 
of different volumes.
Inter-observer agreement and variability
The Bland Altman plot that compared one observer’s vol-
ume measurements with the other’s (Fig. 5) demonstrated 
a mean relative difference for 3D-SI volume measurements 
between the two observers of 0.11% and limits of agreement 
of − 0.63 to 0.84%.
Repeatability and reproducibility of volume and shape 
symmetry measurements in patients
Of the 18 women invited to participate in this validation 
study, 16 agreed. The other two were unable to attend in 
the allocated timeframe. Eleven women had undergone 
mastectomy and reconstruction and 5 had undergone breast 
conservation. The average age was 53 years (SD = 9 years) 
and the average BMI was 24.8 kg/m2 (SD = 4.9 kg/m2).
Volume measurements
The mean CV over three repeated volume measurements 
was 3.9% and 3.8% for observer 1 and 2, respectively. 
No significant correlation was observed between CV and 
breast volume (correlation coefficients 0.025 and − 0.17, 
and p values 0.891 and 0.366, respectively, for observer 
1 and 2), thus justifying the averaging of CV over breast 
volume.
The Bland Altman plot (Fig. 6) demonstrated a mean rela-
tive difference for 3D-SI volume between the two observers 
of − 5.78% with limits of agreement of − 17.76 to 6.2% for 
patients’ breast volume measurements obtained by averaging 
over three estimates.
Shape symmetry measurements
The mean CV of repeated volume measurements was 8.0 and 
14.0% for observer 1 and 2, respectively.
The Bland Altman plot (Fig. 7) demonstrated that the 
mean difference between the observers’ estimates of symme-
try was 0.43 mm, for average symmetry values that ranged 
from about 3.5 mm to about 15.5 mm, with upper limit of 
agreement of 4.01 mm and lower limit of agreement of 
− 3.15 mm.
Fig. 3  Protocol to measure 
breast symmetry, RMS Projec-
tion difference (RMS-PD). a 
AP view of torso, b gridlines 
placed onto image and cropped, 
c torso in craniocaudal view, d 
image rotated laterally, e image 
cropped at level of the anterior 
axillary line, f one-half of torso 
is selected, Image is copied and 
reflected in x = 0
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Fig. 4  a Bland Altman plot of 
agreement between gold stand-
ard and mean Vectra XT for 
Observer 1 for phantom breast 
model volumes, b Bland Alt-
man plot of agreement between 
gold standard and mean Vectra 
XT for observer 2 for phantom 
breast model volumes
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Fig. 5  Bland Altman plot of 
agreement between observers 1 
and 2 for phantom breast model 
volumes
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Discussion
We have demonstrated the ability to assess the volume and 
shape symmetry of breasts in a breast cancer population 
with prior oncological surgery and shown a high degree of 
reproducibility between observers. Invasive breast cancer 
affects approximately 55,000 women a year in the United 
Kingdom [8] and at least 80% have some form of surgery 
[9] that necessitates the best possible aesthetic outcome 
because it influences psychological recovery and qual-
ity of life [10–12]. The ability to objectively measure the 
volume and symmetry of the breasts has the potential to 
profoundly influence surgical planning and thus aesthetic 
outcome.
As was shown in Fig. 4a, b, the study demonstrated 
that the Vectra XT is able to measure the volume of a 
simple breast-shaped object with an average accuracy 
of about 2.2% underestimation of the true volume (one 
observer − 2.17%, the other − 2.28%). Variation in accu-
racy over the volume range studied suggested that most 
of this underestimation occurred at volumes smaller than 
300 cm3, and for larger volumes there may even have 
been a slight overestimation. These trends were consistent 
across the two observers. The intra-observer variation was 
found to be low (mean CV 0.58% over ten estimates for 
one observer and 0.49% for the other). The two observers 
strongly agreed; inter-observer agreement obtained from 
the Bland Altman plot (Fig. 5) was on average within 
0.11% of the volume measured i.e. there was no significant 
bias of one observer relative to the other compared with 
the residual SD of 0.38% seen in Fig. 5.
A similar study of a 3D-SI system designed and made 
in-house by researchers at the University of Glasgow 
was validated using a phantom of the breast [13]. In their 
study, the authors found that on average, relative to the 
gold standard, their 3D-SI volume measurements overes-
timated the volumes by 5%, whereas in this study the bias 
was slightly smaller at about 2% underestimation. Another 
study using phantoms to validate the Minolta Vivid 910 
(Konica Minolta Co Ltd, Osaka, Japan) 3D-SI system 
was undertaken by Kovacs et al. [14] who used ‘dummy 
models’ of the breasts consisting of two mannequins. The 
authors found that there was a lower variance (CV) for 
Fig. 6  Bland Altman plot of 
agreement between observ-
ers 1 and 2 for patients’ breast 
volumes
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Fig. 7  Bland Altman plot of 
agreement between observers 1 
and 2 for breast symmetry
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repeatability of breast volume measurements performed 
by an experienced observer compared to those with less 
experience (lowest CV 1.28%, highest 2.5%). They related 
this to the ability of the observers to accurately mark the 
breast borders on the thoracic wall as per a defined and 
standardised protocol. In our experiment using the plasti-
cine phantoms, the boundaries of the phantom were eas-
ily identifiable, which explains why our intra- and inter-
observer variabilities were low.
The second part of the present study aimed to test the 
intra-observer and inter-observer variation of human breast 
volume and symmetry measurements. The intra-observer 
variation in the human breasts was on average 3.9% for one 
observer and 3.8% for the other, which are much larger than 
the values obtained using the phantoms (around 0.5%). This 
is likely to be due to both the complexity of defining the 
region of interest in human breasts compared to the simple 
outline of the phantoms, and the fact that only three esti-
mates were made in each human breast whereas ten esti-
mates were obtained of each phantom’s volume. We chose 
to use three measurements of the breast volume as in clini-
cal practice it would not be practical to measure the breasts 
more than several times due to time constraints. The mean 
relative difference for volume measurements between the 
two observers was 5.78%, which was smaller than the resid-
ual SD of 6.1% on this Bland Altman plot but probably sig-
nificant in terms of a bias of one observer compared with the 
other. Cochrane et al. [15] identified that excision of greater 
than 10% of the breast volume led to a reduction in patient 
satisfaction. In addition, Sigurdson et al. [16] showed that 
the minimum volume difference detectable by the human 
eye was 50 cm3 by subjective judgment. Therefore, we assert 
that a relative mean difference of 5.78%, which was main-
tained for breasts volumes up to 1000 cm3 and thus equal to 
about 58 cm3 at the largest volume, is adequate.
Mailey et al. [17] conducted a study in 22 patients under-
going breast augmentation whereby two observers measured 
the breast volumes before and after augmentation to investi-
gate the accuracy of measuring breast and implant volume. 
They used the Portrait 3D surgical simulation platform (Axis 
Three, Boston, Massachusetts, USA). The authors found no 
significant difference between their two observers’ estima-
tions of breast volumes pre- or post-operatively, and high 
reliability (intra-class correlation coefficient, ICC all > 0.94). 
In another study, Losken et al. [18] measured the volume of 
19 breasts of patients using the 3dMD system (3dMD LLC, 
Atlanta, Georgia, USA) before they underwent mastectomy 
and used water displacement of the mastectomy specimen as 
the gold standard. They concluded that intra-observer reli-
ability was excellent with an ICC of 0.975 and inter-observer 
reliability was also excellent with an inter-class correlation 
coefficient of 0.968. However, no quantitative measurements 
of repeatability or reproducibility were provided.
The RMS-PD or similar methodology has been used 
as a measure of shape symmetry in other studies [19–23]. 
In our study, population RMS-PD ranged between 3 and 
16 mm (see Fig. 7). Another study [24] found that the aver-
age symmetry score measured using RMS-PD had a range 
of 1.7–12.8 mm in a cohort of 87 women without a history 
of breast surgery. It was significantly higher in patients with 
a higher BMI, cup size, and chest wall circumference. As 
expected, the RMS-PD values in our study were higher since 
they had all undergone surgery.
An objective symmetry score has the potential to be used 
for measurement of aesthetic outcome after surgery. It is 
important, however, to understand what repeatability and 
reproducibility are necessary for a symmetry score to be 
useful in this way. A minimum requirement is that the score 
is significantly different for different subjective assessments 
of aesthetic outcome. One study [20] compared objective 
symmetry scores of this type with subjective scores for 
symmetry in forty-four patients after immediate unilateral 
breast reconstruction with extended latissimus dorsi flap. 
There was a highly significant correlation (p < 0.0001, cor-
relation coefficient = 0.62) between the two scores. We also 
recently published a study demonstrating that RMS-PD sym-
metry significantly agrees (Kruskal Wallis test, p < 0.001) 
with panel assessment of aesthetic outcome in women who 
have undergone breast conserving therapy [25]. In that study, 
patients were grouped according to panel assessment of 
the aesthetic outcome after surgery (poor/fair/good/excel-
lent). The median RMS-PD scores for each group differed 
by approximately 2 mm from those in the next sequential 
group. Therefore, the repeatability (intra-observer highest 
CV < 14%, highest symmetry score in patient 15.5 mm, 
therefore worst SD 2.2 mm) and reproducibility (inter-
observer mean relative difference < 0.5 mm) measured here 
should be sufficient for the method to have clinical value.
This study has demonstrated satisfactory repeatability 
and reproducibility of breast volume and symmetry meas-
urements using the Vectra XT three-dimensional surface 
imaging system. However, these data provide preliminary 
results in a small cohort of patients. Before widespread clini-
cal use, further validation should be undertaken by inde-
pendent breast surgical research groups in a larger cohort of 
patients with a wide variety of body habitus, and who have 
undergone a variety of breast surgery.
Conclusion
We are the first to validate breast volume and symmetry 
measurement using the popular Vectra XT 3D-SI, which is 
essential before widespread use. For volume measurement, 
the intra-observer variation was low (CV < 4%), and mean 
difference between the two observers was acceptable at 
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about 5.8%. For symmetry of the breasts, the intra-observer 
variation was low (CV < 14%) and mean inter-observer dif-
ference was 0.43 mm in a study population for which the 
range of symmetry values was 3–16 mm. This repeatability 
and reproducibility would be adequate for clinical use in 
pre-operative planning of breast surgery and as measures 
of aesthetic outcome after breast cancer surgery. However, 
further validation is required before widespread clinical use.
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